Torisel
Showing 1 - 25 of 129
Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)
Active, not recruiting
- Brain Tumor, Recurrent
- +4 more
- Cytoreductive surgery
- +2 more
-
New York, New York
- +1 more
Jun 9, 2022
Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)
Active, not recruiting
- Advanced Cancer
- Temsirolimus
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022
Advanced Cancers Trial in Houston (Temsirolimus, Metformin)
Active, not recruiting
- Advanced Cancers
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 11, 2022
High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)
Not yet recruiting
- High Grade Glioma
- +3 more
-
Phoenix, ArizonaSt. Joseph's Hospital and Medical Center
Mar 6, 2023
Metastatic Renal Cell Carcinoma Trial in Lebanon, Burlington (Sunitinib, Temsirolimus)
Active, not recruiting
- Metastatic Renal Cell Carcinoma
-
Lebanon, New Hampshire
- +1 more
Aug 9, 2022
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Rochester, Madison (CCI-779,
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
-
Rochester, Minnesota
- +1 more
Jan 12, 2022
Diffuse Intrinsic Pontine Glioma Trial in Houston (Radiation Therapy, Temsirolimus, Vorinostat)
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- Radiation Therapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 5, 2022
Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)
Completed
- Kidney Cancer
- Pazopanib
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 24, 2021
Acute Myeloblastic Leukemia Trial in Germany (sodium chloride solution 0.9%, temsirolimus)
Completed
- Acute Myeloblastic Leukemia
- sodium chloride solution 0.9%
- temsirolimus
-
Berlin, Germany
- +4 more
Nov 10, 2021
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,
Completed
- Adult Anaplastic Astrocytoma
- +8 more
- Laboratory Biomarker Analysis
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 28, 2021
Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)
Active, not recruiting
- Advanced Malignant Neoplasm
- +38 more
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Hemangioendothelioma of Liver Trial in Shanghai (Sirolimus Oral Product, propranolol)
Not yet recruiting
- Hemangioendothelioma of Liver
- Sirolimus Oral Product
- propranolol
-
Shanghai, Shanghai, ChinaShanghai Children's Medical Center Shanghai Jiaotong University
May 23, 2020
Advanced Cancer, Solid Tumor Trial in Houston (Vemurafenib, Everolimus, Temsirolimus)
Completed
- Advanced Cancer
- Solid Tumor
- Vemurafenib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 1, 2020
Advanced Cancer Trial in Houston (Sirolimus, Vorinostat, Everolimus)
Unknown status
- Advanced Cancer
- Sirolimus
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 10, 2020
Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7 Trial in Chicago, Saint Louis
Completed
- Recurrent Breast Carcinoma
- +5 more
- Laboratory Biomarker Analysis
- Temsirolimus
-
Chicago, Illinois
- +1 more
Feb 13, 2020
Sarcoma Trial in Baltimore (temsirolimus plus liposomal doxorubicin)
Completed
- Sarcoma
- temsirolimus plus liposomal doxorubicin
-
Baltimore, MarylandJohns Hopkins University
Mar 8, 2019
Advanced Cancer Trial in Houston (Doxil, Bevacizumab, Temsirolimus)
Completed
- Advanced Cancer
- Doxil
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 9, 2019
Hepatocellular Carcinoma Trial in San Francisco, Chicago (sorafenib with temsirolimus)
Completed
- Hepatocellular Carcinoma
- sorafenib with temsirolimus
-
San Francisco, California
- +1 more
May 7, 2019
Temsirolimus Drug Use Investigation
Completed
- Renal Cell Carcinoma
-
Fukuoka-shi, Fukuoka PREF, JapanKyusyu University Hospital
Sep 14, 2018